Page results
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
Our andrology unit manages patients with andrological conditions including male sterilisation and infertility service, and other disorders of the penis or male genitalia.
-
We offer management of kidney stone disease, including in-house lithotripsy, rigid ureteroscopy, flexible ureterorenoscopy and laser disintegration of stones in ureters and kidneys and percutaneous nephrolithotomy.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
This page is for patients having planned neurosurgery.
File results
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust